FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018581697> ?p ?o ?g. }

• W2018581697 endingPage "2896" @default.
• W2018581697 startingPage "2892" @default.
• W2018581697 abstract "Context: Chemerin is a new adipokine involved in in vitro adipogenesis and insulin resistance and associates with body mass index (BMI) in vivo. Objective: We investigated the role of chemerin in morbid obesity, associated metabolic diseases (insulin resistance, hepatic diseases), and postsurgery-induced weight loss. Setting: This was a prospective study performed at a university hospital. Subjects: Subjects included 60 obese female patients (BMI 50.0 ± 1.0 kg/m−2) being candidates for gastric bypass. Study Design: Patients were examined before and 3, 6, and 12 months after surgery. In 27 patients, chemerin was measured after 2 yr. Main Outcome: Outcomes included chemerin, anthropometric parameters, homeostasis model assessment for insulin resistance index (HOMA-IR), cholesterol, high-density lipoprotein, triglycerides, C-reactive protein, adipokines at all time points; and liver histology and macrophage content in fat at baseline. Results: Chemerin was substantially elevated in obese patients compared with nonobese persons (353.8 ± 18.0 vs. 191 ± 14 ng/ml, P < 0.001). Preoperatively, chemerin concentrations correlated positively with BMI, C-reactive protein, IL-6, HOMA-IR, and the amount of omental macrophages and negatively with high-density lipoprotein levels. Baseline chemerin was elevated in patients with a significant activity score for nonalcoholic fatty liver disease, portal inflammation, fibrosis, and fibroinflammation. After surgery, chemerin decreased significantly to 253.0 ± 14.9 ng/ml after 1 yr and pursued its decrease in patients studied for 2 yr. After surgery, chemerin concentrations positively correlated with triglycerides. The strong decrease of chemerin in the 3 months after surgery was associated with the decrease in HOMA-IR and blood glucose. Conclusions: Chemerin concentrations are elevated in morbidly obese patients and correlated with insulin resistance and markers of liver pathology. Chemerin plasma concentrations decreased after bariatric surgery. This study suggests that chemerin might mediate metabolic alterations in obesity, drastically improving after gastric bypass." @default.
• W2018581697 created "2016-06-24" @default.
• W2018581697 creator A5020607761 @default.
• W2018581697 creator A5020862274 @default.
• W2018581697 creator A5027224797 @default.
• W2018581697 creator A5031987417 @default.
• W2018581697 creator A5038609111 @default.
• W2018581697 creator A5038989175 @default.
• W2018581697 creator A5040329390 @default.
• W2018581697 creator A5081169678 @default.
• W2018581697 creator A5083408547 @default.
• W2018581697 date "2010-06-01" @default.
• W2018581697 modified "2023-10-18" @default.
• W2018581697 title "Chemerin Correlates with Markers for Fatty Liver in Morbidly Obese Patients and Strongly Decreases after Weight Loss Induced by Bariatric Surgery" @default.
• W2018581697 cites W1986082361 @default.
• W2018581697 cites W1991804892 @default.
• W2018581697 cites W1995466366 @default.
• W2018581697 cites W2034067398 @default.
• W2018581697 cites W2042740038 @default.
• W2018581697 cites W2055421595 @default.
• W2018581697 cites W2058355902 @default.
• W2018581697 cites W2067740038 @default.
• W2018581697 cites W2087829753 @default.
• W2018581697 cites W2108823659 @default.
• W2018581697 cites W2117786834 @default.
• W2018581697 cites W2118422675 @default.
• W2018581697 cites W2119773094 @default.
• W2018581697 cites W2134133526 @default.
• W2018581697 cites W2140444503 @default.
• W2018581697 cites W2147727639 @default.
• W2018581697 cites W2168251511 @default.
• W2018581697 doi "https://doi.org/10.1210/jc.2009-2374" @default.
• W2018581697 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20375212" @default.
• W2018581697 hasPublicationYear "2010" @default.
• W2018581697 type Work @default.
• W2018581697 sameAs 2018581697 @default.
• W2018581697 citedByCount "222" @default.
• W2018581697 countsByYear W20185816972012 @default.
• W2018581697 countsByYear W20185816972013 @default.
• W2018581697 countsByYear W20185816972014 @default.
• W2018581697 countsByYear W20185816972015 @default.
• W2018581697 countsByYear W20185816972016 @default.
• W2018581697 countsByYear W20185816972017 @default.
• W2018581697 countsByYear W20185816972018 @default.
• W2018581697 countsByYear W20185816972019 @default.
• W2018581697 countsByYear W20185816972020 @default.
• W2018581697 countsByYear W20185816972021 @default.
• W2018581697 countsByYear W20185816972022 @default.
• W2018581697 countsByYear W20185816972023 @default.
• W2018581697 crossrefType "journal-article" @default.
• W2018581697 hasAuthorship W2018581697A5020607761 @default.
• W2018581697 hasAuthorship W2018581697A5020862274 @default.
• W2018581697 hasAuthorship W2018581697A5027224797 @default.
• W2018581697 hasAuthorship W2018581697A5031987417 @default.
• W2018581697 hasAuthorship W2018581697A5038609111 @default.
• W2018581697 hasAuthorship W2018581697A5038989175 @default.
• W2018581697 hasAuthorship W2018581697A5040329390 @default.
• W2018581697 hasAuthorship W2018581697A5081169678 @default.
• W2018581697 hasAuthorship W2018581697A5083408547 @default.
• W2018581697 hasBestOaLocation W20185816971 @default.
• W2018581697 hasConcept C126322002 @default.
• W2018581697 hasConcept C134018914 @default.
• W2018581697 hasConcept C151730666 @default.
• W2018581697 hasConcept C171089720 @default.
• W2018581697 hasConcept C194832188 @default.
• W2018581697 hasConcept C199901988 @default.
• W2018581697 hasConcept C2776954865 @default.
• W2018581697 hasConcept C2777391703 @default.
• W2018581697 hasConcept C2778535154 @default.
• W2018581697 hasConcept C2778772119 @default.
• W2018581697 hasConcept C2779134260 @default.
• W2018581697 hasConcept C2779343474 @default.
• W2018581697 hasConcept C2780221984 @default.
• W2018581697 hasConcept C511355011 @default.
• W2018581697 hasConcept C71924100 @default.
• W2018581697 hasConcept C86803240 @default.
• W2018581697 hasConceptScore W2018581697C126322002 @default.
• W2018581697 hasConceptScore W2018581697C134018914 @default.
• W2018581697 hasConceptScore W2018581697C151730666 @default.
• W2018581697 hasConceptScore W2018581697C171089720 @default.
• W2018581697 hasConceptScore W2018581697C194832188 @default.
• W2018581697 hasConceptScore W2018581697C199901988 @default.
• W2018581697 hasConceptScore W2018581697C2776954865 @default.
• W2018581697 hasConceptScore W2018581697C2777391703 @default.
• W2018581697 hasConceptScore W2018581697C2778535154 @default.
• W2018581697 hasConceptScore W2018581697C2778772119 @default.
• W2018581697 hasConceptScore W2018581697C2779134260 @default.
• W2018581697 hasConceptScore W2018581697C2779343474 @default.
• W2018581697 hasConceptScore W2018581697C2780221984 @default.
• W2018581697 hasConceptScore W2018581697C511355011 @default.
• W2018581697 hasConceptScore W2018581697C71924100 @default.
• W2018581697 hasConceptScore W2018581697C86803240 @default.
• W2018581697 hasIssue "6" @default.
• W2018581697 hasLocation W20185816971 @default.
• W2018581697 hasOpenAccess W2018581697 @default.
• W2018581697 hasPrimaryLocation W20185816971 @default.
• W2018581697 hasRelatedWork W1982589044 @default.
• W2018581697 hasRelatedWork W1993587668 @default.

• next